Immune and stromal remodeling underlies radiation-induced heart injury: insights from single-cell transcriptomics
Frontiers in Cardiovascular Medicine · 02.07.2026 · 13
DOI: 10.3389/fcvm.2026.1836858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.07.2026. Verfasst von Xia Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, Ch…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Radiation-induced heart injury (RIHI) is a major late toxicity of thoracic radiotherapy, yet the cellular and molecular mechanisms driving its progression remain poorly defined.
Methods
Single-cell RNA sequencing (scRNA-seq) was performed on rat hearts and matched peripheral blood mononuclear cells (PBMCs) 12 weeks after whole-heart irradiation (20 Gy) or sham control, profiling 38,941 cardiac cells across 15 types and 41,097 PBMCs across 9 types. Differential expression, pathway enrichment, pseudotime, and ligand–receptor interaction analyses were conducted. Key findings in endothelial cells and fibroblasts were validated by Western blotting and flow cytometry.
Results
Major cardiac populations, including cardiomyocytes, endothelial cells (ECs), fibroblasts, neutrophils, macrophages, T cells, NK cells, and B cells, were defined in control and RIHI hearts. Following irradiation, ECs showed distinct subtype shifts with marked MHC-II upregulation, while fibroblasts exhibited iron accumulation, pro-inflammatory activation, and antigen-presenting properties. These stromal alterations coincided with myeloid activation (macrophage and IL-1β⁺ neutrophil programs) and T/NK cell polarization toward cytotoxic yet partially exhausted states, together with enhanced B-cell antigen presentation. Collectively, these findings delineate a stromal–immune cascade linking radiation injury to chronic cardiac inflammation.
Conclusion
RIHI progresses through a stromal-immune cascade where EC and fibroblast immunogenic reprogramming initiates sustained myeloid and lymphoid activation, creating a pro-inflammatory cardiac microenvironment. These findings highlight non-hematopoietic antigen presentation as a therapeutic target in thoracic radiotherapy, particularly when combined with immune checkpoint inhibitors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, China.
- Shanxi Provincial Key Laboratory for Translational Nuclear Medicine and Precision Protection, Taiyuan, Shanxi, China.
- Nursing College of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.
- Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.
Zitieren
APA
Yan, X., Zhao, J., Shi, Q., Yan, R., Li, S., & Song, J. (2026). Immune and stromal remodeling underlies radiation-induced heart injury: insights from single-cell transcriptomics. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1836858
Vancouver
Yan X, Zhao J, Shi Q, Yan R, Li S, Song J. Immune and stromal remodeling underlies radiation-induced heart injury: insights from single-cell transcriptomics. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1836858
BibTeX
@article{Yan2026,
author = {Yan, Xia and Zhao, JiaYi and Shi, QinYing and Yan, Rui and Li, Sijin and Song, Jianbo},
title = {Immune and stromal remodeling underlies radiation-induced heart injury: insights from single-cell transcriptomics},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1836858}
}
EUVIMED